17th MESOT Congress Topics: -

• Pre-Transplant Assessment.

• Pre-Transplant Workup.

• Donor Management

• Expanded Criteria Donors

• DSA Criteria for Desensitization.

• Management of HCV in Solid Organ Transplantation.

• Immunosuppression

  • Induction Therapy

  • Maintenance Immunosuppression

  • Future Immunosuppression and Unmet needs.

• Liver Transplantation Experience.

• Liver Transplantation Outcomes.

• Liver Transplantation: HCC.

• Kidney Transplantation.

• Kidney Transplantation Surgery.

• Kidney Transplantation Experience.

• Advances in Kidney Transplantation.

• Transplanting the Untransplantible

• Kidney Paired Donation.

• ABO Incompatible Transplantation.

• HLA Incompatible Transplantation.

• Heart and Lung Transplantation.

• Transplanting the morbidly Obese: Surgical Issues.

• Bone Marrow/Stem Cell Transplantation.

• Cornea: Corneal Grafting, where are we?

• Pancreas, Islet Cell and Intestinal Transplantation.

• Pediatric Transplantation.

• Transplantation in the COVID-19 Era.

• Anti-COVID-19 Drugs and Immunosuppression Interaction.

• Immunology.

  • HLA DR Typing and Incompatibility.

  • Immune Tolerance

  • Rejection

  • HLA Antibodies

• Post-transplant Complications.

  • Recurrent Disease after Transplantation

  • Post-Transplant Infection

  • Post-Transplant Diabetes

  • Post-Transplant Hypertension

  • Post-Transplant Dyslipidemia

  • Post-Transplant Anemia

  • Post-Transplant BMD

  • Post-Transplant Obesity

  • Transplant Oncology

• Graft Survival.

• Facing the Failing Graft.

• Organ Donation, Coordination and Organization.

• Organ Procurement.

• Brain Stem Death

• Donation after brain death vs Cardiac death.

• Ethics and Legislation

• MESOT GENERAL ASSEMBLY.

• Declaration of Istanbul.